Literature DB >> 25586843

Conquering rotavirus: from discovery to global vaccine implementation.

Julie E Bines1, Carl D Kirkwood.   

Abstract

Rotavirus, the commonest cause of severe dehydrating gastroenteritis world-wide, was discovered less than 50 years ago. It causes about 450,000 deaths per year in children <5 years of age and hospitalises millions more. Rotavirus vaccines have been shown to have a major impact on hospital admissions due to rotavirus gastroenteritis and all-cause gastroenteritis and reduce mortality in developing countries. In Australia, there has been a 71% decrease in rotavirus hospitalisations in children 0-5 years of age. From the discovery of rotavirus as the major causative agent for severe gastroenteritis, through vaccine development and vaccine post-marketing surveillance activities, Australian scientists and clinicians have played a significant role in the global effort to reduce the burden of rotavirus infection.
© 2015 The Authors. Journal of Paediatrics and Child Health © 2015 Paediatrics and Child Health Division (Royal Australasian College of Physicians).

Entities:  

Keywords:  diarrhoea; gastroenteritis; rotavirus

Mesh:

Substances:

Year:  2015        PMID: 25586843     DOI: 10.1111/jpc.12815

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  7 in total

1.  A combination of scGOS/lcFOS with Bifidobacterium breve M-16V protects suckling rats from rotavirus gastroenteritis.

Authors:  M Rigo-Adrover; S Saldaña-Ruíz; K van Limpt; K Knipping; J Garssen; J Knol; A Franch; M Castell; F J Pérez-Cano
Journal:  Eur J Nutr       Date:  2016-04-25       Impact factor: 5.614

Review 2.  Modulation of rotavirus severe gastroenteritis by the combination of probiotics and prebiotics.

Authors:  Guadalupe Gonzalez-Ochoa; Lilian K Flores-Mendoza; Ramona Icedo-Garcia; Ricardo Gomez-Flores; Patricia Tamez-Guerra
Journal:  Arch Microbiol       Date:  2017-06-20       Impact factor: 2.552

3.  Preventive Effect of a Synbiotic Combination of Galacto- and Fructooligosaccharides Mixture With Bifidobacterium breve M-16V in a Model of Multiple Rotavirus Infections.

Authors:  Maria Del Mar Rigo-Adrover; Kees van Limpt; Karen Knipping; Johan Garssen; Jan Knol; Adele Costabile; Àngels Franch; Margarida Castell; Francisco José Pérez-Cano
Journal:  Front Immunol       Date:  2018-06-11       Impact factor: 7.561

4.  Sexual Dimorphism Has Low Impact on the Response against Rotavirus Infection in Suckling Rats.

Authors:  Carla Morales-Ferré; Ignasi Azagra-Boronat; Malén Massot-Cladera; Àngels Franch; Margarida Castell; María José Rodríguez-Lagunas; Francisco J Pérez-Cano
Journal:  Vaccines (Basel)       Date:  2020-06-29

5.  Thermostable, Dissolvable Buccal Film Rotavirus Vaccine Is Highly Effective in Neonatal Gnotobiotic Pig Challenge Model.

Authors:  Casey Hensley; Peng Zhou; Sofia Schnur; Hassan M Mahsoub; Yu Liang; Min-Xuan Wang; Caroline Page; Lijuan Yuan; Victor Bronshtein
Journal:  Vaccines (Basel)       Date:  2021-04-30

6.  Electron-Beam Inactivation of Human Rotavirus (HRV) for the Production of Neutralizing Egg Yolk Antibodies.

Authors:  Jill W Skrobarczyk; Cameron L Martin; Sohini S Bhatia; Suresh D Pillai; Luc R Berghman
Journal:  Front Immunol       Date:  2022-03-14       Impact factor: 7.561

7.  Genipin inhibits rotavirus-induced diarrhea by suppressing viral replication and regulating inflammatory responses.

Authors:  Jong-Hwa Kim; Kiyoung Kim; Wonyong Kim
Journal:  Sci Rep       Date:  2020-09-28       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.